Development of an <i>in vivo</i>-mimic silkworm infection model with <i>Mycobacterium avium</i> complex-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of an in vivo-mimic silkworm infection model with Mycobacterium avium complex

Published:2020-12-31 Issue:6 Volume:14 Page:287-295
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Yagi Akiho¹,Yamazaki Hiroyuki¹,Terahara Takeshi²,Yang Taehui²,Hamamoto Hiroshi³,Imada Chiaki²,Tomoda Hiroshi⁴,Uchida Ryuji¹

Affiliation:

1. Department of Natural Product Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.

2. Graduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, Tokyo, Japan.

3. Institute of Medical Mycology, Teikyo University, Tokyo, Japan.

4. Microbial Chemistry and Medical Research Laboratories, Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/6/14_2020.03099/_pdf

Reference27 articles.

1. 1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012; 185:881-886.

2. 2. Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016; 22:1116-1117.

3. 3. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175:367-416.

4. 4. Shirley M. Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease. Drugs. 2019; 79:555-562.

5. 5. Hamamoto H, Urai M, Ishii K, et al. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat Chem Biol. 2015; 11:127-133.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of anti-Mycobacterium avium-intracellulare disease drugs in silkworms;Scientific Reports;2024-07-23

2. Silkworm model of bacterial infection facilitates the identification of lysocin E, a potent, ultra-rapid bactericidal antibiotic;The Journal of Antibiotics;2024-05-21

3. New liposidomycin congeners produced by Streptomyces sp. TMPU-20A065, anti-Mycobacterium avium complex agents with therapeutic efficacy in a silkworm infection model;The Journal of Antibiotics;2024-05-08

4. Development of a silkworm infection model for evaluating the virulence of <i>Mycobacterium intracellulare</i> subspecies estimated using phylogenetic tree analysis based on core gene data;Drug Discoveries & Therapeutics;2024

5. Tuberculosis: Experimental Models, Innovations, and Challenges;Recent Advances in Pharmaceutical Innovation and Research;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3